During the past decade, SGS LSS Clinical Pharmacology Unit Antwerp conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 2 clinical trials were completed, i.e. on average, 8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SGS LSS Clinical Pharmacology Unit Antwerp" #1 sponsor was "Galapagos NV" with 18 trials, followed by "Boehringer Ingelheim" with 5 trials sponsored, "Chiesi Farmaceutici S.p.A." with 2 trials sponsored, "Medicines for Malaria Venture" with 2 trials sponsored and "Selecta Biosciences, Inc." with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SGS LSS Clinical Pharmacology Unit Antwerp" #1 collaborator was "SGS Life Sciences, a division of SGS Belgium NV" with 3 trials as a collaborator, "FGK Representative Service B.V., The Netherlands" with 2 trials as a collaborator, "Institute of Tropical Medicine, Belgium" with 2 trials as a collaborator, "PrimeVigilance Ltd., UK" with 2 trials as a collaborator and "Sanaria Inc." with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "SGS LSS Clinical Pharmacology Unit Antwerp" are "Healthy" (22 trials), "Smoking Cessation" (2 trials), "Asthma" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Healthy Volunteers" (1 trials). Many other conditions were trialed in "SGS LSS Clinical Pharmacology Unit Antwerp" in a lesser frequency.

Most popular intervention types in "SGS LSS Clinical Pharmacology Unit Antwerp" are "Drug" (28 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Placebo single dose" (4 trials), "Placebo multiple doses" (3 trials), "BI 1595043" (2 trials) and "Midazolam" (2 trials). Other intervention names were less common.

The vast majority of trials in "SGS LSS Clinical Pharmacology Unit Antwerp" are 16 trials for "Male" genders, 12 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "SGS LSS Clinical Pharmacology Unit Antwerp". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in SGS LSS Clinical Pharmacology Unit Antwerp, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SGS LSS Clinical Pharmacology Unit Antwerp, 30 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".